| Value | ₹3.54 Cr |
|---|
BSE filing, NSE: GLAXO. Summary written from the filing by ALFA Finder's alert engine.
GlaxoSmithKline Pharmaceuticals Ltd: key numbers
- Share price
- ₹2,494.30
- Market cap
- ₹42,255 Cr
- Revenue (annual)
- ₹3,822 Cr
- Net profit (annual)
- ₹1,036 Cr
- P/E (TTM)
- 39.6×Sector 45.9×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 4.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GlaxoSmithKline Pharmaceuticals Ltd
All →GlaxoSmithKline Pharmaceuticals Board Meeting Date
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on 3rd November 2026 to consider and approve its unaudited financial results for the quarter ended 30th September 2026.
GlaxoSmithKline Pharmaceuticals Other Announcement
GlaxoSmithKline Pharmaceuticals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI listing regulations.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.
GlaxoSmithKline Pharmaceuticals Annual General Meeting
GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.
GlaxoSmithKline Pharmaceuticals Price Movement Clarification
GlaxoSmithKline Pharmaceuticals clarified that recent trading volume increases are purely market-driven. The company confirmed all material disclosures have been made according to SEBI regulations.
GlaxoSmithKline Pharmaceuticals Business Update
GlaxoSmithKline Pharmaceuticals received an income tax refund intimation of Rs 4.99 Crore for the assessment year 2025-2026.
- Value
- ₹4.99 Cr
Other legal & regulatory announcements
All →Bharti Airtel Legal & Regulatory
Bharti Airtel received a TRAI order imposing a financial disincentive of ₹54.06 lakh for CCPR non-compliance. The company disagrees with the order and plans to seek reversal.
- Value
- ₹0.54 Cr
YES Bank Legal & Regulatory
Yes Bank's AT-1 bonds remain unrestored after the Supreme Court's 15 October 2026 judgment. Axis Trustee threatens contempt proceedings unless the bank acts within three days.
Net Avenue Technologies Legal & Regulatory
Net Avenue Technologies disclosed that the GST department has appealed against an order dropping a show cause notice proceeding. The company will update investors upon further communication.
Fine Organic Industries Legal & Regulatory
Fine Organic's offices and manufacturing units faced a Maharashtra GST inspection on October 30, 2026. The company says operations are unaffected and it expects no material impact.
Tilaknagar Industries Legal & Regulatory
Tilaknagar Industries disclosed a DRI search under Section 105 of the Customs Act on October 22, 2026. The search is part of an industry-wide HSN review, and the company reports no impact as of now.
Rallis India Legal & Regulatory
Rallis India received an income tax give-effect order dropping a Rs.408 crore demand for AY 2022-23. The company will get a refund of Rs.8.31 crore including Rs.1.79 crore interest.
- Value
- ₹8.31 Cr